biospecimen_aliquot__bcr_aliquot_barcode	tcga-e9-a2jt-01a-22d-a18p-09
biospecimen_aliquot__bcr_aliquot_uuid	4a0f9f07-6b43-4b77-864a-e3c744d4d835
biospecimen_aliquot__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_aliquot__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113390560
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-10-04
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a18p
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e9-a2jt-01a-22d
biospecimen_analyte__bcr_analyte_uuid	d2882c88-cb7b-41c2-a792-c02afb33d243
biospecimen_analyte__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_analyte__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e9-a2jt
biospecimen_diagnostic_slides__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	49c2b936-3b1a-4014-8b43-26d483def53a
biospecimen_normal_control__bcr_patient_barcode	tcga-e9-a2jt
biospecimen_normal_control__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_portion__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_portion__bcr_portion_barcode	tcga-e9-a2jt-01a-22
biospecimen_portion__bcr_portion_uuid	a7887cb1-0299-4665-ab4b-efdac86b240b
biospecimen_portion__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_portion__date_of_creation	2011-08-03
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	22
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e9-a2jt-01a-22d
biospecimen_protocol__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_protocol__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_sample__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_sample__bcr_sample_uuid	5fce29d3-4250-4696-b691-d4bc953c21cd
biospecimen_sample__days_to_collection	94
biospecimen_sample__initial_weight	260
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e9-a2jt.c70325c1-54eb-41bf-b77c-d92fada8d23e.pdf
biospecimen_sample__pathology_report_uuid	c70325c1-54eb-41bf-b77c-d92fada8d23e
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	013e6c9f-a4fb-4588-9159-562bd6f2721c
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a24a
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e9-a2jt-01a-11-a24a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	14
biospecimen_shipment_portion__shipment_portion_month_of_shipment	11
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
biospecimen_slide__bcr_sample_barcode	tcga-e9-a2jt-01a
biospecimen_slide__bcr_slide_barcode	tcga-e9-a2jt-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	7607ff14-463c-439c-ab91-0691679d0045
biospecimen_slide__image_file_name	tcga-e9-a2jt-01a-02-tsb.7607ff14-463c-439c-ab91-0691679d0045.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	60
biospecimen_slide__percent_tumor_cells	40
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e9-a2jt
biospecimen_tumor_sample__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
clinical_drug__bcr_drug_barcode	tcga-e9-a2jt-d34098
clinical_drug__bcr_drug_uuid	9899a8bd-e368-4788-944f-e1685da002c6
clinical_drug__bcr_patient_barcode	tcga-e9-a2jt
clinical_drug__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
clinical_drug__form_completion_date	2012-7-30
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	27
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-e9-a2jt-f34097
clinical_follow_up__bcr_followup_uuid	bd6e3218-fd63-434b-8453-99fc7dc05314
clinical_follow_up__bcr_patient_barcode	tcga-e9-a2jt
clinical_follow_up__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-7-30
clinical_follow_up__last_contact_days_to	261
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	63
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e9-a2jt
clinical_patient__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
clinical_patient__birth_days_to	-23318
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-12-20
clinical_patient__gender	female
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	23
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	10
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	cytology (e.g. peritoneal or pleural fluid)
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a2jt
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e9
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e9-a2jt
clinical_radiation__bcr_patient_uuid	b35fbe19-0e6d-427e-b9be-ee3527b5fca6
clinical_radiation__bcr_radiation_barcode	tcga-e9-a2jt-r34099
clinical_radiation__bcr_radiation_uuid	0bd58064-0b71-450b-9df6-ecd92445be83
clinical_radiation__form_completion_date	2012-7-30
clinical_radiation__radiation_adjuvant_fractions_total	23
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	87
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	58
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	46
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A2JT-01A-22D-A18P-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A2JT-01A-22D-A18P-09.bed.meta
manually_curated__id	tcga-e9-a2jt-01a-22d-a18p-09
manually_curated__md5sum	1cbfb23d82ec55974ff8986316dd3ae5
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	4a0f9f07-6b43-4b77-864a-e3c744d4d835
manually_curated__tumor_tag	brca
